[HIV-HBV coinfection and the liver].
Aaron
L
L
Service de Médecine Interne, Hôpital Necker, Paris, France.
Carnot
F
F
Pialoux
G
G
D001706:Biopsy; D016049:Didanosine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D006509:Hepatitis B / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D006801:Humans; D019259:Lamivudine / Q000627:therapeutic use; D008103:Liver Cirrhosis / Q000473:pathology / Q000821:virology; D008297:Male; D008875:Middle Aged; D019438:Ritonavir / Q000009:adverse effects / Q000627:therapeutic use; D019258:Saquinavir / Q000627:therapeutic use; D018119:Stavudine / Q000627:therapeutic use
D019259:Lamivudine; D018119:Stavudine; D016049:Didanosine; D019258:Saquinavir; D019438:Ritonavir
Co-infection VIH-VHB et foie.